Keywords: body weight, glycated hemoglobin (HbA 1c ), efficacy, glucagon-like peptide-1 receptor agonist (GLP-1RA), oral, semaglutide, subcutaneous, type 2 diabetes Introduction Evidence from trials and real-world studies in patients with type 2 diabetes (T2D) indicates that the risk of complications may be reduced by providing sustained glycemic control and that near-normal glycated hemoglobin (HbA 1c ) levels should be achieved as early as possible in the T2D trajectory (1, 2)
You know, youre hearing all those celebrities doing it, so it felt to me only right to try it and to be able to give my feedback to people who really need it, Raibick explains
Knowing that duration of treatment varies by individual helps set realistic expectations
I feel better & have noticed less bloatingThe only thing I regret is I wish I could have been introduced to this sooner
doi: 10.1073/pnas.0501988102 74 HajnalACovasaMBelloNT
P for interaction = .109)